SC 13G 1 miromatrix_13g.htm SC 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. )*

Miromatrix Medical Inc.

(Name of Issuer)

Common Stock, par value $0.00001 per share

(Title of Class of Securities)

60471P108

(CUSIP Number)

February 11, 2022

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o	Rule 13d-1(b)
x	Rule 13d-1(c)
o	Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 60471P108

13G

Page 2 of 8


1.	Names Of Reporting Persons I.R.S. Identification No. Of Above Persons (Entities Only) GAGNON SECURITIES LLC

2.	check the appropriate box if a group			(a) o (b) x
3.	sec use only

4.	citizenship or place of organization DELAWARE LIMITED LIABILITY COMPANY
number of shares beneficially owned by each reporting person with:		5.	sole voting power		0
		6.	shared voting power		650,444
		7.	sole dispositive power		0
		8.	shared dispositive power		684,984
9.	aggregate amount beneficially owned by each reporting person				684,984
10.	check box if the aggregate amount in row (9) excludes certain shares (See Instructions)				o
11.	percent of class represented by amount in row (9)				3.4%
12.	type of reporting person (See Instructions)				IA, BD

CUSIP No. 60471P108

13G

Page 3 of 8


1.	Names Of Reporting Persons GAGNON ADVISORS, LLC

2.	check the appropriate box if a group			(a) o (b) x
3.	sec use only

4.	citizenship or place of organization DELAWARE LIMITED LIABILITY COMPANY
number of shares beneficially owned by each reporting person with:		5.	sole voting power		0
		6.	shared voting power		229,802
		7.	sole dispositive power		0
		8.	shared dispositive power		229,802
9.	aggregate amount beneficially owned by each reporting person				229,802
10.	check box if the aggregate amount in row (9) excludes certain shares (See Instructions)				o
11.	percent of class represented by amount in row (9)				1.1%
12.	type of reporting person (See Instructions)				IA

CUSIP No. 60471P108

13G

Page 4 of 8


1.	Names Of Reporting Persons NEIL GAGNON

2.	check the appropriate box if a group			(a) o (b) x
3.	sec use only

4.	citizenship or place of organization USA
number of shares beneficially owned by each reporting person with:		5.	sole voting power		65,711
		6.	shared voting power		915,651
		7.	sole dispositive power		65,711
		8.	shared dispositive power		952,753
9.	aggregate amount beneficially owned by each reporting person				1,018,464
10.	check box if the aggregate amount in row (9) excludes certain shares (See Instructions)				o
11.	percent of class represented by amount in row (9)				5.0%
12.	type of reporting person (See Instructions)				IN

CUSIP No. 60471P108

13G

Page 5 of 8

Item 1.

(a)	Name of Issuer:	Micromatrix Medical Inc.

(b)	Address of Issuer’s Principal	10399 West 70th Street
	Executive Offices:	Eden Prairie, MN 55344

Item 2.

(a)

Name of Person Filing:

Neil Gagnon has sole voting and dispositive power over 65,711 shares of the Issuer’s common stock, par value $0.00001 per share (the “Common Stock”). In addition, Mr. Gagnon has shared voting power over 915,651 shares of the Issuer’s Common Stock and shared dispositive power over 952,753 shares of Common Stock.

Mr. Gagnon is the managing member and principal owner of Gagnon Securities LLC (“GS”), an investment adviser registered with the U.S. Securities and Exchange Commission (“SEC”) under the Investment Advisers Act of 1940, as amended (the “Advisers Act”), and a registered broker-dealer, in its role as investment manager to several customer accounts, foundations, partnerships and trusts (collectively, the “Accounts”) to which it furnishes investment advice. GS and Mr. Gagnon may be deemed to share voting power with respect to 650,444 shares of Common Stock held in the Accounts and dispositive power with respect to 684,984 shares of the Issuer’s Common Stock held in the Accounts. GS and Mr. Gagnon expressly disclaim beneficial ownership of all securities held in the Accounts.

Mr. Gagnon is also the Chief Executive Officer of Gagnon Advisors, LLC (“Gagnon Advisors”), an investment adviser registered with the SEC under the Advisers Act. Mr. Gagnon and Gagnon Advisors, in its role as investment manager to Gagnon Investment Associates, LLC (“GIA”), a private investment fund, may be deemed to share voting and dispositive power with respect to the 229,802 shares of the Issuer’s Common Stock held by GIA. Gagnon Advisors and Mr. Gagnon expressly disclaim beneficial ownership of all securities held by GIA.

(b)	Address of Principal Business Office	1370 Ave. of the Americas, 24^th Floor
	or, if none, Residence:	New York, NY 10019

(c)	Citizenship:	Gagnon Securities LLC	Delaware limited liability company
		Gagnon Advisors, LLC	Delaware limited liability company
		Neil Gagnon	USA

(d)	Title of Class of Securities:	Common Stock, $0.00001 per share

(e)	CUSIP Number:	60471P108

CUSIP No. 60471P108

13G

Page 6 of 8


Item 3.	If this statement is filed pursuant to §§240.13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

(a)	o	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b)	o	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c)	o	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d)	o	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

(e)	o	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)	o	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)	o	A parent holding company or control person in accordance with § 13d-1(b)(1)(ii)(G);

(h)	o	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)	o	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15U.S.C. 80a-3);

(j)	o	A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);

(k)	o	Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

CUSIP No. 60471P108

13G

Page 7 of 8

Item 4.

Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a)	Amount beneficially owned:	Gagnon Securities LLC	684,984
		Gagnon Advisors, LLC	229,802
		Neil Gagnon	1,018,464

(b)	Percent of class:	Gagnon Securities LLC	3.4%
		Gagnon Advisors, LLC	1.1%
		Neil Gagnon	5.0%

		Calculation of percentage of beneficial ownership is based on 20,254,645 shares of Common Stock outstanding as of November 11, 2021 as disclosed in the issuer’s quarterly report on Form 10-Q dated November 15, 2021.

(c)	Number of shares as to which the person has:

(i)	Sole power to vote or to direct the vote:	Gagnon Securities LLC	0
		Gagnon Advisors, LLC	0
		Neil Gagnon	65,711

(ii)	Shared power to vote or to direct the vote:	Gagnon Securities LLC	650,444
		Gagnon Advisors, LLC	229,802
		Neil Gagnon	915,651

(iii)	Sole power to dispose or to direct the disposition of:	Gagnon Securities LLC	0
		Gagnon Advisors, LLC	0
		Neil Gagnon	65,711

(iv)	Shared power to dispose or to direct the disposition of:	Gagnon Securities LLC	684,984
		Gagnon Advisors, LLC	229,802
		Neil Gagnon	952,753

Item 5.	Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

The Accounts described above in Item 2 have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, securities held in their respective accounts. To the knowledge of the Reporting Persons the interest in any such account does not exceed 5% of the class of securities. Except to the extent described herein, the Reporting Person disclaims beneficial ownership of all such securities.

Items 7 – 9.

Not Applicable.

CUSIP No. 60471P108

13G

Page 8 of 8


Item 10.	Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Section 230.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 16, 2022


	NEIL GAGNON

	/s/ Neil Gagnon

	GAGNON SECURITIES LLC

	/s/ Neil Gagnon
	Name: Neil Gagnon
	Title: Managing Member

	GAGNON ADVISORS, LLC

	/s/ Neil Gagnon
	Name: Neil Gagnon
	Title: Chief Executive Officer

SEC Form SC 13G filed by Miromatrix Medical Inc.